PubRank
Search
About
Jaap Oostendorp
Author PubWeight™ 23.25
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
N Engl J Med
2009
5.79
2
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Clin Cancer Res
2008
2.06
3
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.
Proc Natl Acad Sci U S A
2010
1.67
4
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Clin Cancer Res
2008
1.66
5
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.
Clin Cancer Res
2009
1.27
6
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.
Int J Cancer
2009
1.26
7
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
J Transl Med
2013
1.02
8
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
Cancer Immunol Immunother
2012
0.97
9
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.
Int J Cancer
2012
0.94
10
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
Eur J Immunol
2013
0.93
11
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
Cancer Immunol Immunother
2013
0.89
12
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial.
Int J Cancer
2012
0.88
13
Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes.
Am J Physiol Lung Cell Mol Physiol
2005
0.87
14
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responses.
J Infect Dis
2010
0.84
15
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.
Cancer Immunol Immunother
2013
0.82
16
Development of a nose cream containing the synthetic antimicrobial peptide P60.4Ac for eradication of methicillin-resistant Staphylococcus aureus carriage.
J Pharm Sci
2013
0.78
17
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
Cancer Immunol Immunother
2015
0.77